Shanghai Pharmaceutical Holding Co. Ltd.

Pharmaceuticals
China
Earnings Per Share Growth (%)11.03%
Cost of Goods Sold (US$ Millions)$14,276
Current Liabilities (US$ Millions)$6,071
Total Assets (US$ Millions)$8,559
Long Term Debt$14
Return on Equity10.34%
Revenue (US$ Millions)$16,247
Total Company Assets$11,447
Revenue Growth (%)14.20%
Net Income (US$ Millions)$443
Earnings Per Share (US$)$11.03
Total Equity (US$ Millions)$4,609
Profit Margin (%)2.73%
Debt To Equity Ratio (%)0.00%
Inventory Turnover$2,324